Ithaca, NY, United States of America

Neel Madhukar

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Cornell University. Active years: 2022-2024.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Neel Madhukar: Innovator in Drug Toxicity Prediction

Introduction

Neel Madhukar is a prominent inventor based in Ithaca, NY (US). He has made significant contributions to the field of computational systems, particularly in improving the accuracy of drug toxicity predictions. With a total of 2 patents, his work is paving the way for advancements in pharmaceutical safety.

Latest Patents

Madhukar's latest patents focus on computational systems and methods designed to enhance the accuracy of drug toxicity predictions. In these implementations, the solution determines a first structural vector of a chemical based on its chemical structure. Additionally, the system identifies a first target vector based on at least one gene target for the chemical. By utilizing both the structural and target vectors, the system generates a toxicity predictor score for the chemical, which is crucial for assessing its safety.

Career Highlights

Neel Madhukar is affiliated with Cornell University, where he continues to innovate and contribute to research in drug toxicity. His work is instrumental in developing methodologies that can significantly impact the pharmaceutical industry.

Collaborations

Madhukar collaborates with notable colleagues, including Olivier Elemento and Kaitlyn Gayvert. Their combined expertise fosters an environment of innovation and research excellence.

Conclusion

Neel Madhukar's contributions to drug toxicity prediction through his innovative patents and collaborations highlight his role as a key figure in the field. His work not only advances scientific understanding but also enhances the safety of pharmaceuticals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…